Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs

Journal of Veterinary Diagnostic Investigation

Volumn 20, Issue 5, 2008, Pages 644-649

  Rossi, Silvia ^a   Rossi, Gabriele ^b   Giordano, Alessia ^b   Paltrinieri, Saverio ^b  

^a Clinica Veterinaria Malpensa   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Biomarker; Dogs; Enzymatic method; Heart disease; Homocysteine; Renal failure

Indexed keywords

CANIS FAMILIARIS;

BILIRUBIN; BIOLOGICAL MARKER; HEMOGLOBIN; HOMOCYSTEINE; TRIACYLGLYCEROL;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; INFLAMMATION; INJURY; KIDNEY FAILURE; METABOLISM; REFERENCE VALUE;

ANIMALS; BILIRUBIN; BIOLOGICAL MARKERS; DOG DISEASES; DOGS; GASTROINTESTINAL DISEASES; HEART DISEASES; HEMOGLOBINS; HOMOCYSTEINE; HUMANS; INFLAMMATION; KIDNEY FAILURE; REFERENCE VALUES; TRIGLYCERIDES; WOUNDS AND INJURIES;

EID: 55449092916     PISSN: 10406387     EISSN: None     Source Type: Journal    
DOI: 10.1177/104063870802000520     Document Type: Article

References (19)

1. Andersson A, Isaksson A, Hultberg B: 1992, Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem 38:1311-1315.
2. Chandler ML, Payne-James JJ: 2006, Prospective evaluation of a peripherally administered three-in-one parenteral nutrition product in dogs. J Small Anim Pract 47:518-523.
3. Dou C, Xia D, Zhang L, et al.: 2005, Development of a novel enzymatic cycling assay for total homocysteine. Clin Chem 51:1987-1989.
4. Eldibany MM, Caprini JA: 2007, Hyperhomocysteinemia and thrombosis: an overview. Arch Pathol Lab Med 131:872-884.
5. Friedman AN, Bostom AG, Selhub J, et al.: 2001, The kidney and homocysteine metabolism. J Am Soc Nephrol 12:2181-2189.
6. Gardner IA, Greiner M: 2006, Receiver-operating characteristic curves and likelihood ratios: improvements over traditional methods for the evaluation and application of veterinary clinical pathology tests. Vet Clin Pathol 35:8-17.
7. Herrmann M, Taban-Shomal O, Hubner U, et al.: 2006, A review of homocysteine and heart failure. Eur J Heart Fail 8:571-576.
8. Kjelgaard-Hansen M, Luntang-Jensen M, Willesenb J, Jensen AL: 2007, Measurement of serum interleukin-10 in the dog. Vet J 173:361-365.
9. Lumsden JH: 2000, Laboratory test method validation. Rev Méd Vét 151:623-630.
10. Martinez Subiela S, Ceròn J: 2005, Effects of hemolysis, lipemia, hyperbilirrubinemia, and anticoagulants in canine C-reactive protein, serum amyloid A, and ceruloplasmin assays. Can Vet J 46:625-629.
11. U. McMichael MA, Freeman LM, Selhub J, et al.: 2000, Plasma homocysteine, B vitamins and amino acid concentration in cats with cardiomyopaths and arterial thromboembolism. J Vet Intern Med 14:507-512.
12. Muntner P, Hamm L, Kusek JW, et al.: 2004, The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140:9-17.
13. Refsum H, Smith AD, Ueland PM, et al.: 2004, Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50:3-32.
14. Ruaux CG, Steiner JM, Williams DA: 2001, Metabolism of amino acids in cats with severe cobalamin deficiency. Am J Vet Res 62:1852-1858.
15. Ruaux CG, Steiner JM, Williams DA: 2005, Early biochemical and clinical responses to cobalamin supplementation in cats with signs of gastrointestinal disease and severe hypocobalaminemia. J Vet Intern Med 19:155-160.
16. Stam F, van Guidener C, Schalkwijk CG, et al.: 2003, Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 18:892-898.
17. Stanger O, Herrmann W, Pietrzik K, et al.: 2003, DACHLIGA Homocystein (German, Austrian and Swiss Homocysteine Society): Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392-1403.
18. Ueland PM, Nygard O, Vollset SE, Refsum H: 2001, The Hordaland homocysteine studies. Lipids 36(Suppl. 1):S33-S39.
19. Westgard JO, ed.: 2003, Method validation. In: Basic method validation, 2nd ed., pp. 156-157. Westgard QC, Madison, WI.